The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care

BACKGROUND: Molecular signatures are being increasingly incorporated into cancer classification systems. DNA methylation-based central nervous system (CNS) tumor classification is being recognized as having the potential to aid in cases of difficult histopathological diagnoses. Here, we present our...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Epigenetics
Autores principales: Karimi, Shirin, Zuccato, Jeffrey A., Mamatjan, Yasin, Mansouri, Sheila, Suppiah, Suganth, Nassiri, Farshad, Diamandis, Phedias, Munoz, David G., Aldape, Kenneth D., Zadeh, Gelareh
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896594/
https://ncbi.nlm.nih.gov/pubmed/31806041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0766-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares